Edible Exosome-Like Nanoparticles Show Early Promise Against Liver Cancer in Preclinical Studies
A new review finds edible source-derived exosome-like nanoparticles show preclinical promise against hepatocellular carcinoma, but clinical translation faces major hurdles.
